8-KShareholder MattersExhibits & Filings

BIOGEN INC. 8-K Report, Shareholder Vote Results (Jun 5, 2020)

Filed June 5, 2020For Securities:BIIB

Summary

Biogen Inc. (BIIB) filed an 8-K on June 5, 2020, reporting the results of its 2020 Annual Meeting of Stockholders held on June 3, 2020. The meeting's primary focus was on the voting outcomes for key corporate governance matters. All twelve nominees for the Board of Directors were elected, though the vote tallies show a notable number of 'Votes Against' for several directors, indicating some shareholder dissent. The company also successfully ratified the appointment of PricewaterhouseCoopers LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2020, with a very strong majority in favor. Finally, an advisory vote on executive compensation was also approved, albeit with a less overwhelming margin than the auditor ratification. For investors, these results generally indicate continued support for management's proposed slate of directors and the company's auditor. However, the 'Votes Against' on director elections, particularly for some nominees, warrants further attention to understand the underlying shareholder concerns. The advisory vote on executive compensation also shows a split, suggesting a portion of shareholders may be scrutinizing compensation packages. While no significant governance failures were reported, these nuances in voting outcomes provide important context for shareholder sentiment and corporate oversight.

Key Highlights

  • 1All twelve director nominees were successfully elected to the Board of Directors for a one-year term.
  • 2Significant 'Votes Against' were recorded for several director nominees, indicating potential shareholder concerns or a lack of full support for all candidates.
  • 3PricewaterhouseCoopers LLP was overwhelmingly ratified as Biogen's independent registered public accounting firm for fiscal year 2020.
  • 4An advisory vote on executive compensation was approved by stockholders.
  • 5The 'Votes For' margin on executive compensation was narrower than that for director elections and auditor ratification.
  • 6A substantial number of broker non-votes were recorded for director elections and executive compensation, typical for such meetings.

Frequently Asked Questions

Yes, while all twelve director nominees were elected, several received a notable number of 'Votes Against.' For example, Stelios Papadopoulos received approximately 26.9 million 'Votes Against,' and Eric K. Rowinsky received approximately 26.7 million 'Votes Against.' This indicates that a portion of the shareholders did not fully support these nominees.

Stockholders overwhelmingly ratified the selection of PricewaterhouseCoopers LLP as Biogen's independent registered public accounting firm for the fiscal year ending December 31, 2020. The 'Votes For' significantly outnumbered 'Votes Against' and abstentions, with very few dissenting votes cast.

The advisory vote on executive compensation was approved by stockholders. However, the margin was less decisive than for the auditor ratification, with approximately 22.5 million 'Votes Against' and a significant number of abstentions and broker non-votes.

Broker non-votes occur when a broker holding shares in 'street name' for a beneficial owner does not vote on a particular proposal because the beneficial owner has not provided voting instructions. They are relevant as they can impact the total votes cast and potentially the outcome of closely contested proposals, although in this filing, the proposals passed despite these non-votes.